skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Potential sources of stem cells as a regenerative therapy for Parkinson's disease

Review

(2698) Views  (710) Full article downloads

Authors: Abir Oueida El-Sadik

Published Date December 2010 Volume 2010:3 Pages 183 - 191
DOI: http://dx.doi.org/10.2147/SCCAA.S14626

Abir Oueida El-Sadik
Department of Anatomy and Embryology, Scientific Research Unit, Female Health Science College, King Saud University, Riyadh, Kingdom of Saudi Arabia

Abstract: Stem cells are believed to hold enormous promise as potential replacement therapy in the treatment of neurodegenerative diseases such as Parkinson's disease (PD). Stem cells were investigated to be the alternative therapeutic source capable of differentiating into dopamine (DA) neurons. Multiple important signaling factors were recorded for the induction of DA neuronal traits from mouse embryonic stem cells (ESCs) such as fibroblast growth factor 8, sonic hedgehog, and Wnt 1. Recent protocols were described for the differentiation of human ESCs into DA neurons, achieving high efficiency of DA neuronal derivation. Despite that, the use of human ESCs is still ethically controversial. The transcription factors necessary for DA neuron development from adult neural stem cells (NSCs), such as Pitx3, Nurr1, En-1, En-2, Lmx1a, Lmx1b, Msx1, and Ngn2, were investigated. In addition to replacement of lost DA neurons, adult NSCs were recorded to provide neuroprotective and neurogenic factors for the mesencephalon. In addition, induced pluripotent stem cells and bone marrow-derived mesenchymal stem cells represent reliable stem cell sources of DA neurons. Future studies are recommended to provide further insight into the regenerative capacity of stem cells needed for the treatment of PD.

Keywords: dopamine, embryonic stem cells, neural stem cells, Parkinson's disease, induced pluripotent stem cells, mesenchymal stem cells




 

Other articles by Dr Abir El-Sadik



Readers of this article also read:

Gene transfection in primary stem-like cells of giant cell tumor of bone
Delivered growth factor therapy to improve healing after rotator cuff repair
Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities
Neural stem cell sex dimorphism in aromatase (CYP19) expression: a basis for differential neural fate
Emerging options for the management of age-related macular degeneration with stem cells
Isolation, characterization, and gene expression analysis of Wharton’s jelly-derived mesenchymal stem cells under xeno-free culture conditions
Stem cells: a model for screening, discovery and development of drugs
Potential clinical applications of adult human mesenchymal stem cell (Prochymal®) therapy
Engraftment of donor mesenchymal stem cells in chimeric BXSB includes vascular endothelial cells and hepatocytes
Evolution of the clonogenic potential of human epidermal stem/progenitor cells with age
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University